NCT02175680View on ClinicalTrials.gov

Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

April 16, 2014

Primary Completion Date

February 2, 2015

Study Completion Date

February 2, 2015

Conditions
HIVHuman Immunodeficiency Virus
Interventions
DRUG

PRO 140

CCR5 Antagonist

OTHER

Historical data

Historical data (i.e., time to HIV-1 RNA viral load \> 500 copies/mL of 29 days).

Trial Locations (1)

94115

Quest Clinical Research, San Francisco

Sponsors

Lead Sponsor

CytoDyn, Inc.

Collaborators (1)

Amarex Clinical Research
All Listed Sponsors
collaborator

Amarex Clinical Research

OTHER

lead

CytoDyn, Inc.

INDUSTRY

NCT02175680 - Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection | Biotech Hunter | Biotech Hunter